15:49 IST
NSE
Business Update
Gland Pharma Business Update
Gland Pharma announced that the USFDA completed a routine GMP inspection of its Visakhapatnam facility with zero Form 483 observations.
Gland Pharma Ltd
Gland Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹3,150.60
- Market cap
- ₹51,988 Cr
- Revenue (annual)
- ₹6,431 Cr
- Net profit (annual)
- ₹1,027 Cr
- P/E (TTM)
- 46.1×Sector 47.3×
- Promoter holding
- 51.77%-0.06% QoQ
- FII holding
- 8.74%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 7Earnings Call 6Management Change 5Employee Stock Options 4Board Meeting Outcome 4Other Announcement 3Legal & Regulatory 3Business Update 3Financial Results 2Results Update 1Promoter Selling 1Product Launch 1New Order Win 1Merger & Restructuring 1Capital Structure Change 1Capacity Expansion 1Board Meeting Date 1Acquisition 1
Time
3 announcements with these filters
09:37 IST
BSE
Business Update
Gland Pharma Business Update
Gland Pharma signed a strategic CDMO manufacturing agreement with a global pharmaceutical company. The partnership has an annualized revenue potential of approximately ₹855-950 Crore.
- Value
- ₹855.0 Cr
09:37 IST
NSE
Business Update
Gland Pharma Business Update
Gland Pharma signed a manufacturing and supply agreement with a global partner for sterile injectables. The partnership targets revenue from 2029 with 55 initial SKUs.